Voriconazole *
REQUESTING AND COLLECTING

Collection:
Collect samples at steady state. Collect before next dose (trough

sample).

Initial sampling within first 2 - 5 days of therapy, however may not be

at steady state, therefore repeated sampling may be required within 2

- 5 days. Gel separator tubes should not be used.
Container(s):
EDTA (5 mL purple-top) - Preferred

Serum, no gel (10 mL red-top) - Acceptable

GENERAL INFORMATION

Availability:
Test performed Monday, Tuesday, Wednesday and Thursday (samples

in lab by 1:30pm) Results available following day

Reference Intervals:
Suggested Therapeutic Target:

[Prophylaxis & treatment]: Trough: >1 mg/L

Toxic Range: Trough: >4-6 mg/L

NOTE: A higher target (e.g. 2 mg/L) should be used if there is disease

with poor prognosis (e.g. CNS infection, extensive disease,

disseminated infection).

Laboratory:
Clinical Pharmacology (8382-9184)

Patient Results:
(02) 8382-9100
Synonyms:
VFEND

Clinical Hyperlink:
Voriconazole - SydPath Fact Sheet
.
INSTRUCTIONS FOR REFERRING LABORATORIES
Handling & Transport:

Centrifuge, separate plasma and freeze within 3 hours of collection.

Transport frozen.
___________________________________________________________________________________________________________________________________

INSTRUCTIONS FOR HANDLING AT SYDPATH
SydPath Handling:

Data Entry Code:
VOR

SydPath Division:
Clinical Pharmacology

.

Date/Time published: 30/03/2020 17:35:51
First Previous Next Last